Abstract
Two distinct types of systemic amyloidosis—transthyretin (ATTR) and light chain (AL)—account for the majority of cardiac amyloidosis (CA), which have been considered mutually exclusive. Diagnostic confusion can arise when both proteins are identified from an amyloid deposit. We present a rare occurrence of histopathologically confirmed concomitant ATTR and AL CA captured on 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scan and 18F-flutemetamol (FMM) PET/CT.
Original language | English |
---|---|
Pages (from-to) | 460-461 |
Number of pages | 2 |
Journal | Clinical Nuclear Medicine |
Volume | 50 |
Issue number | 5 |
DOIs | |
State | Published - 1 May 2025 |
Bibliographical note
Publisher Copyright:Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Keywords
- F-flutemetamol
- amyloid PET
- amyloidosis
- concomitant
- light chain
- transthyretin